Belantamab-mafodotin (Belamaf) is an IgG1 monoclonal antibody directed against the B-cell maturation antigen (BCMA) expressed by myeloma cells and conjugated with a direct agent against microtubules, monomethyl auristatin F (MMAF). The gene discussed is TNFRSF17; the disease is plasma cell myeloma.